MiniMed Group is trading 7.23% down at $18.10 as analysts have significantly lowered their earnings expectations ahead of its September 1, 2026, first-quarter earnings report. - Forecast EPS is 9 cents, a substantial reduction from 35 cents a year earlier; consensus revenue is $828.43 million. - Wells Fargo recently reduced its price target to $22. - The broader market is nearly flat, and no earnings results have been released yet.